发明名称 |
COMPOUNDS INCLUDING MAP KINASE INTERACTING KINASES 1 AND 2 (MNK1 AND MNK2) MODULATORS AND ABL AND ABL (T315I) INHIBITORS, AND USES THEREOF |
摘要 |
<p>The present invention relates to certain piperazine-based compounds that act as inhibitors of the MAP kinase interacting kinases MNK2a, MNK2b, MNK1a, and MNK1b and/or as ABL or ABL (T315I) inhibitors. The invention further relates to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the preparation of a medicament for the prophylaxis and treatment of cancer, inflammatory and Alzheimer disease conditions, as well as methods of treatment of these disorders.</p> |
申请公布号 |
WO2014088519(A1) |
申请公布日期 |
2014.06.12 |
申请号 |
WO2013SG00519 |
申请日期 |
2013.12.06 |
申请人 |
AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR) |
发明人 |
CHERIAN, JOSEPH;DURAISWAMY, ATHISAYAMANI JEYARAJ;NACRO, KASSOUM |
分类号 |
C07D403/12;A61K31/496;A61P3/00;A61P25/28;A61P29/00;A61P35/00;C07D401/12;C07D413/12;C07D471/04 |
主分类号 |
C07D403/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|